| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | UNITED THERAPEUTICS CORP CMN | Feb 5, 2026 | |
| Sell | United Therapeutics Corporat | Oct 31, 2025 | |
| Buy | United Therapeutics Corporat | Oct 30, 2025 | |
| Sell | United Therapeutics Corporat | Oct 30, 2025 | |
| Sell | UNITED THERAPEUTICS CORP | Aug 22, 2025 | |
| Buy | UNITED THERAPEUTICS CORP | Aug 7, 2025 | |
| Sell | UNITED THERAPEUTICS CORP | Jun 27, 2025 | |
| Buy | United Therapeutics Corporat | Jun 11, 2025 | |
| Sell | UNITED THERAPEUTICS CMN | Feb 25, 2025 | |
| Sell | UNITED THERAPEUTICS CORP | Nov 20, 2024 |
This page tracks congressional stock trading activity in United Therapeutics Corporation (UTHR) in the Healthcare sector. Disclosed Capitol has indexed 46 disclosed congressional trades involving UTHR. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of March 2026 — Disclosed Capitol has tracked 46 disclosed congressional trades in United Therapeutics Corporation (UTHR) — 31:9 sell-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| 2026-02-05 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| 2025-10-31 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| 2025-08-22 | Michael McCaul | R | Sale | $1,001 - $15,000 |
| 2025-08-07 | Michael McCaul | R | Purchase | $15,001 - $50,000 |
| 2025-06-27 | Michael McCaul | R | Sale | $1,001 - $15,000 |
| 2025-06-11 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| 2025-02-25 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2024-11-20 | Michael McCaul | R | Exchange | $1,001 - $15,000 |
Across the 46 disclosed congressional trades in United Therapeutics Corporation (UTHR), members of Congress have reported 9 buys and 31 sells. The average 30-day alpha vs. the S&P 500 is -1.29%.